Literature DB >> 33942140

ImmunoPET of CD38 with a radiolabeled nanobody: promising for clinical translation.

Sixiang Shi1, Shreya Goel2, Xiaoli Lan3, Weibo Cai4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33942140      PMCID： PMC8266735          DOI： 10.1007/s00259-021-05329-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  16 in total

Review 1.  Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?

Authors:  Susanne Lütje; Georg Feldmann; Markus Essler; Peter Brossart; Ralph A Bundschuh
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 10.057

2.  [89Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study.

Authors:  Human Adams; Ewoudt Mw van de Garde; Coline Hm van Moorsel; Danielle J Vugts; Guus Ams van Dongen; Jan C Grutters; Ruth G Keijsers
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-12-15

3.  Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.

Authors:  Marleen Keyaerts; Catarina Xavier; Johannes Heemskerk; Nick Devoogdt; Hendrik Everaert; Chloé Ackaert; Marian Vanhoeij; Francois P Duhoux; Thierry Gevaert; Philippe Simon; Denis Schallier; Christel Fontaine; Ilse Vaneycken; Christian Vanhove; Jacques De Greve; Jan Lamote; Vicky Caveliers; Tony Lahoutte
Journal:  J Nucl Med       Date:  2015-10-08       Impact factor: 10.057

4.  CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.

Authors:  Limo Chen; Lixia Diao; Yongbin Yang; Xiaohui Yi; B Leticia Rodriguez; Yanli Li; Pamela A Villalobos; Tina Cascone; Xi Liu; Lin Tan; Philip L Lorenzi; Anfei Huang; Qiang Zhao; Di Peng; Jared J Fradette; David H Peng; Christin Ungewiss; Jonathon Roybal; Pan Tong; Junna Oba; Ferdinandos Skoulidis; Weiyi Peng; Brett W Carter; Carl M Gay; Youhong Fan; Caleb A Class; Jingfen Zhu; Jaime Rodriguez-Canales; Masanori Kawakami; Lauren Averett Byers; Scott E Woodman; Vassiliki A Papadimitrakopoulou; Ethan Dmitrovsky; Jing Wang; Stephen E Ullrich; Ignacio I Wistuba; John V Heymach; F Xiao-Feng Qin; Don L Gibbons
Journal:  Cancer Discov       Date:  2018-07-16       Impact factor: 39.397

5.  Development of zirconium-89 PET for in vivo imaging of alpha-klotho.

Authors:  Wei Ling Lau; Christopher Liang; Han Liu; Karanveer Singh; Jogeshwar Mukherjee
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

6.  PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody.

Authors:  Gaochao Lv; Xiaorong Sun; Ling Qiu; Yan Sun; Ke Li; Qingzhu Liu; Qi Zhao; Songbing Qin; Jianguo Lin
Journal:  J Nucl Med       Date:  2019-06-28       Impact factor: 11.082

7.  Noninvasive imaging of immune responses.

Authors:  Mohammad Rashidian; Edmund J Keliher; Angelina M Bilate; Joao N Duarte; Gregory R Wojtkiewicz; Johanne Tracey Jacobsen; Juanjo Cragnolini; Lee Kim Swee; Gabriel D Victora; Ralph Weissleder; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

8.  Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.

Authors:  Mohammad Rashidian; Jessica R Ingram; Michael Dougan; Anushka Dongre; Katherine A Whang; Camille LeGall; Juan J Cragnolini; Brian Bierie; Monica Gostissa; James Gorman; Gijsbert M Grotenbreg; Atul Bhan; Robert A Weinberg; Hidde L Ploegh
Journal:  J Exp Med       Date:  2017-06-30       Impact factor: 14.307

9.  Early Phase I Study of a 99mTc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.

Authors:  Yan Xing; Gitasha Chand; Changchun Liu; Gary J R Cook; Jim O'Doherty; Lingzhou Zhao; Nicholas C L Wong; Levente K Meszaros; Hong Hoi Ting; Jinhua Zhao
Journal:  J Nucl Med       Date:  2019-02-22       Impact factor: 10.057

Review 10.  Nanobody: the "magic bullet" for molecular imaging?

Authors:  Rubel Chakravarty; Shreya Goel; Weibo Cai
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556
View more
  1 in total

Review 1.  Immuno-Imaging (PET/SPECT)-Quo Vadis?

Authors:  Carsten S Kramer; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2022-05-23       Impact factor: 4.927
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.